Editorial: Angiogenesis blockade for the treatment of gastrointestinal cancer
Alessandro Passardi,
Alessandro Bittoni,
Zhigang Bai,
Zhongtao Zhang,
Cornelis Sier,
Yulong He,
Endrit Shahini,
Antonio Giovanni Solimando
Affiliations
Alessandro Passardi
Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) “Dino Amadori”, Meldola, Italy
Alessandro Bittoni
Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) “Dino Amadori”, Meldola, Italy
Zhigang Bai
Department of General Surgery, Beijing Friendship Hospital, Capital Medical University and National Clinical Research Center for Digestive Diseases, Beijing, China
Zhongtao Zhang
Department of General Surgery, Beijing Friendship Hospital, Capital Medical University and National Clinical Research Center for Digestive Diseases, Beijing, China
Cornelis Sier
Department of Surgery, Leiden University Medical Center, Leiden, Netherlands
Yulong He
Cyrus Tang Hematology Center, Collaborative Innovation Center of Hematology, National Clinical Research Center for Hematologic Diseases, State Key Laboratory of Radiation Medicine and Protection, Cam-Su Genomic Resources Center, Soochow University, Suzhou, China
Endrit Shahini
Gastroenterology Unit, National Institute of Gastroenterology - IRCCS “Saverio de Bellis”, Castellana Grotte, Bari, Italy
Antonio Giovanni Solimando
Guido Baccelli Unit of Internal Medicine, Department of Precision and Regenerative Medicine and Ionian Area - (DiMePRe-J), University of Bari “A. Moro”, Bari, Italy
